Papers
4
Total Citations
52
H-Index
2
About
Dr. Ching-Wei Yang is a urologic surgeon and researcher whose work centers on optimizing oncologic outcomes in robot-assisted radical prostatectomy (RARP), with a particular focus on the interplay between nerve-sparing techniques and surgical margins. His major contributions include a landmark single-surgeon Asian population study (2021, 36 citations) that identified key predictors of positive surgical margins (PSM) and biochemical recurrence (BCR), providing critical insights for surgical planning in this demographic. Dr. Yang further advanced the field by clarifying the nuanced effects of nerve-sparing procedures on margin status in a 2022 study (12 citations), addressing previously ambiguous results and offering evidence-based guidance for balancing functional preservation with oncologic safety. His scholarly engagement is demonstrated through published replies to international commentaries, reflecting his active role in refining the discourse around RARP outcomes. Affiliated with Cheng-Hsin General Hospital and National Yang Ming Chiao Tung University in Taipei, as well as the Wellcome EPSRC Centre for Interventional and Surgical Sciences, Dr. Yang’s work directly informs clinical decision-making, helping surgeons reduce recurrence risks while preserving quality of life for prostate cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4